Avenue Therapeutics Stock to Reverse Split on Friday, April 26th (NASDAQ:ATXI)

Shares of Avenue Therapeutics, Inc. (NASDAQ:ATXI) are set to reverse split on the morning of Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, April 26th.

Avenue Therapeutics Trading Down 29.6 %

Avenue Therapeutics stock traded down $0.04 during midday trading on Wednesday, reaching $0.09. The company’s stock had a trading volume of 12,284,611 shares, compared to its average volume of 4,543,282. Avenue Therapeutics has a 52 week low of $0.09 and a 52 week high of $1.25. The business has a 50-day moving average price of $0.15 and a 200-day moving average price of $0.21. The stock has a market cap of $4.17 million, a PE ratio of -0.07 and a beta of -0.24.

Avenue Therapeutics (NASDAQ:ATXI) last released its earnings results on Monday, March 18th. The company reported $0.56 earnings per share (EPS) for the quarter.

About Avenue Therapeutics

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.